Skadden And Latham & Watkins Advised On Otsuka Pharmaceutical's $1.12 Billion Acquisition Of Jnana Therapeutics Link to read full News: legaleraonline.com/global/deal-st… #OtsukaPharmaceutical #JnanaTherapeutics #Acquisition #LegalEra

🧵 Otsuka Pharmaceutical Acquires Jnana Therapeutics for $800M to Develop PKU Treatment #OtsukaPharmaceutical #JnanaTherapeutics #Pku #Phenylketonuria #Jnt #RapidChemoproteomicsPlatform #RareMetabolicDisorder #BiotechAcquisition

This is why I prefer Pocari to Aquarius. #OtsukaPharmaceutical By the way, the sales copy is not Japan-only stuff.

#CINP2024 Tokyo Co-sponsored Session ⚡Sponsored by Otsuka Pharmaceutical Co, Ltd. #CINP2024 #OtsukaPharmaceutical #cinp # recovery CSS1 Symposium May 23rd (Thu) 15:45-17:45 Room 1 (Hall C) 'To Achieve Personal Goals for Patients with Schizophrenia in Patient Centered Care'

Esperion: Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia $ESPR, #Esperion, #OtsukaPharmaceutical, #OtsukaPharma, #Otsuka, #Hypercholesterolemia crweworld.com/article/news-p…

⚡Heads Up! - #CINP2024 tokyo Co-sponsored Session ⚡ Sponsored by Otsuka Pharmaceutical Co, Ltd. on May 23 – 25 🎉 For more details, please visit CINP2024 Website! cinp2024.org #CINP2024 #OtsukaPharmaceutical #cinp #recovery

FDA grants Otsuka's Sibeprenlimab breakthrough therapy designation in IgAN business-news-today.com/fda-grants-ots… #Sibeprenlimab #OtsukaPharmaceutical #VisterraInc #FDABreakthrough #KidneyDiseaseTreatment #IgANephropathy #ClinicalResearch

Otsuka Highlights P-III Study Results of AVP-786 for Treating Agitation in Patients with Dementia due to Alzheimer's Disease #otsukapharmaceutical #avp786 #alzheimersdisease #clinicaltrial #safety #efficacy #tolerability #piii #agitation #dementia #patients

Promising Alzheimer's treatment fails to meet primary endpoint in phase 3 trial noah-news.com/gb/en/health/2… #Alzheimer'sdisease #clinicaltrials #OtsukaPharmaceutical

💊 Japanese pharmaceutical company Otsuka Pharmaceutical has secured exclusive marketing rights to Ionis Pharmaceuticals' hereditary angioedema (HAE) drug candidate, donidalorsen, in the European market. #OtsukaPharmaceutical #IonisPharmaceuticals #HereditaryAngioedema

<WORK> #OtsukaPharmaceutical #CalorieMate aoi-pro.com/en/work/202312… ★AOI Pro. Staff Pr: Mana Hisamatsu, Takahide Suzuki Dir: Hiroki Ono(CluB_A) PM: Manami Kanzaki, Yukina Okamoto(GR) Cas: Mai Ikeda, Azumi Matsumoto, Yurika Kagami

#OtsukaPharmaceutical on Friday posted top-line data from two Phase III studies. #OtsukaPharma #Pharmaceuticals #Centanafadine #BioSpace hubs.li/Q0275_Ll0

#OtsukaPharmaceutical on Friday posted top-line data from two Phase III studies. #OtsukaPharma #Pharmaceuticals #Centanafadine #BioSpace hubs.li/Q0273lnz0

🧴💦 otsuka.co.jp/ulos/ #ULOS #MensCosmetics #OtsukaPharmaceutical #ウルオス #メンズコスメティックス #大塚製薬

$MSSTF #OtsukaPharmaceutical to Acquire #MindsetPharma newsfilecorp.com/release/179197… #Cannabis #PotStocks #Acquisitions